WHO ICTRP trial
Antibody avidity and immunological memory induced by oral cholera vaccination
ISRCTN11806026 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN11806026 |
|---|---|
| Public title | Antibody avidity and immunological memory induced by oral cholera vaccination |
| Scientific title | Clinical trial to study antibody avidity and immunological memory induced by oral cholera vaccination |
| Primary sponsor | Göteborg University Vaccine Research Institute (GUVAX) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Sweden |
| Conditions | Diarrhoea caused by enterotoxigenic Escherichia coli (ETEC) and Vibrio cholerae bacteria Infections and Infestations Infectious diarrhoea NOS |
| Interventions | All subjects will receive identical treatment during the first stage (primary two dose vaccination) and hence this part of the study will not be randomised or blinded. During the second stage (late booster vaccination), subjects will be… |
| Registration date | Jun 9, 2016 |
| Target size | 60 |
| Secondary IDs | 2016-002080-33;1.1 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: